Finance

Lists
Why is SBFM up 75,92%?
Dive Deeper
SBFM:NASDAQ
Sunshine Biopharma Inc
0,70 USD
+75,92%
(+0,30) 1D
1,14 USD
+62,81% (+0,44)
Pre-market
Closed: 7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBFM...
Open
0,41 USD
High
1,56 USD
Low
0,40 USD
Mkt. cap
3,00 млн
Avg. vol.
707,48 миң
Volume
42,62 млн
52-wk high
24,30 USD
52-wk low
0,36 USD
EPS
-10,03 USD
Beta
1,35
Shares outstanding
4,31 млн
No. of employees
50
Open
0,41 USD
High
1,56 USD
Low
0,40 USD
Mkt. cap
3,00 млн
Avg. vol.
707,48 миң
Volume
42,62 млн
52-wk high
24,30 USD
52-wk low
0,36 USD
EPS
-10,03 USD
Beta
1,35
Shares outstanding
4,31 млн
No. of employees
50
News stories
From web sources and news partners
About Sunshine Biopharma Inc
CEO-
Employees50
Founded2006
HeadquartersФорт Лодердейл, Флорида, Америка Кошмо Штаттары
Sector-
Websitesunshinebiopharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
9,42 млн
8,58 млн
8,09 млн
9,26 млн
Cost of goods sold
6,34 млн
5,55 млн
5,91 млн
6,84 млн
Cost of revenue
6,34 млн
5,55 млн
5,91 млн
6,84 млн
Research and development expenses
119,30 миң
73,50 миң
31,72 миң
13,22 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,27 млн
4,39 млн
3,34 млн
3,81 млн
Operating expense
3,61 млн
4,69 млн
3,58 млн
4,04 млн
Total operating expenses
9,95 млн
10,24 млн
9,48 млн
10,88 млн
Operating income
-531,96 миң
-1,66 млн
-1,40 млн
-1,61 млн
Other non operating income
-
-
103,32 миң
-
EBT including unusual items
-1,02 млн
-1,73 млн
-1,24 млн
-1,56 млн
EBT excluding unusual items
-456,36 миң
-1,60 млн
-1,24 млн
-1,56 млн
Income tax expense
-137,44 миң
408,37 миң
-
-
Effective tax rate
13,46%
-23,57%
-
-
Other operating expenses
119,91 миң
126,54 миң
129,66 миң
138,49 миң
Net income
-883,82 миң
-2,14 млн
-1,24 млн
-1,56 млн
Net profit margin
-9,39%
-24,96%
-15,38%
-16,88%
Earnings per share
-
-
-
-
Interest and investment income
75,35 миң
57,47 миң
48,43 миң
48,82 миң
Interest expense
-
-
-
-
Net interest expenses
75,35 миң
57,47 миң
48,43 миң
48,82 миң
Depreciation and amortization charges
95,82 миң
98,92 миң
76,86 миң
77,97 миң
EBITDA
-435,80 миң
-1,56 млн
-1,32 млн
-1,53 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору